Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 revenue guidance. Get details here.

Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 revenue guidance. Get details here.

Insulet stock crashed Wednesday after lowering sales guidance for its body-worn insulin pump in the back half of the year.